OrbiMed Capital GP VIII LLC: insider trades.
OrbiMed Capital GP VIII LLC reported 7 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 2 open-market purchases ($25.0M) and 2 sales ($9.1M), across 3 companies.
- Transactions
- 7
- Purchases (P)
- 2
- Sales (S)
- 2
- Companies
- 3
- Name as filed
- OrbiMed Capital GP VIII LLC
Companies
| Company | Relationship | Transactions |
|---|---|---|
| BlossomHill Therapeutics, Inc. (BLSM) | Director | 3 |
| Scribe Therapeutics, Inc. (SCTX) | Director | 2 |
| Sionna Therapeutics, Inc. (SION) | Director | 2 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-10 | BlossomHill Therapeutics, Inc. | C | 1,039,996 | — | 1,039,996 | Form 4 |
| 2026-08-10 | BlossomHill Therapeutics, Inc. | C | 1,049,283 | — | 2,089,279 | Form 4 |
| 2026-08-10 | BlossomHill Therapeutics, Inc. | P | 625,000 | $16 | 2,714,279 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | P | 1,000,000 | $15 | 1,348,825 | Form 4 |
| 2026-07-27 | Scribe Therapeutics, Inc. | C | 348,825 | — | 348,825 | Form 4 |
| 2026-07-07 | Sionna Therapeutics, Inc. | S | 85,918 | $44.86 | 2,469,959 | Form 4 |
| 2026-06-30 | Sionna Therapeutics, Inc. | S | 115,844 | $45.5 | 2,555,877 | Form 4 |
Questions
What stock did OrbiMed Capital GP VIII LLC buy or sell?
OrbiMed Capital GP VIII LLC reported 7 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 2 open-market purchases ($25.0M) and 2 sales ($9.1M), across 3 companies.
Is OrbiMed Capital GP VIII LLC the same person as other filers with this name?
This page covers SEC CIK 1845804 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Plain-text version for agents and LLMs: /insiders/orbimed-capital-gp-viii-llc-1845804.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.